Exelixis
EXEL
#1695
Rank
C$13.88 B
Marketcap
$48.63
Share price
0.52%
Change (1 day)
69.29%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company